Department of Psychological Brain Sciences, University of California, Santa Barbara, United States.
Laboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, United States.
Drug Alcohol Depend. 2021 Mar 1;220:108518. doi: 10.1016/j.drugalcdep.2021.108518. Epub 2021 Jan 10.
Hnrnph1 is a validated quantitative trait gene for methamphetamine behavioral sensitivity that encodes for heterogeneous nuclear ribonucleoprotein H1 (hnRNP H1). This RNA-binding protein is involved in all stages of RNA metabolism that impacts mesocorticolimbic dopamine neurotransmission to influence addiction-related behavior.
We characterized the alcohol behavioral phenotypes of mice heterozygous for a deletion in the first coding exon of Hnrnph1 (Hnrnph1+/-). We examined alcohol intake under both continuous- and limited-access procedures, as well as alcohol-induced place-conditioning. Follow-up studies examined genotypic differences in the psychomotor-activating and sedative-hypnotic effects of acute and repeated alcohol, and a behavioral test battery was employed to determine the effects of Hnrnph1 deletion on the manifestation of negative affect during alcohol withdrawal.
Relative to wild-type (WT) controls, Hnrnph1+/- males exhibited blunted intake of high alcohol concentrations under both drinking procedures. Hnrnph1 deletion did not impact the conditioned rewarding properties of low-dose alcohol, but reversed the conditioned place-aversion elicited by higher alcohol doses (2 and 4 g/kg), with more robust effects in male versus female mice. No genotypic differences were observed for alcohol-induced locomotor activity. Hnrnph1+/- mice exhibited a modest increase in sensitivity to alcohol's sedative-hypnotic effects, but did not differ from WT mice with regard to tolerance to alcohol's sedative-hypnotic effects or alcohol metabolism, Inconsistent effects of Hnrnph1 deletion were observed in models for withdrawal-induced negative affect.
These data identify Hnrnph1 as a novel, male-selective, driver of alcohol consumption and high-dose alcohol aversion that is potentially relevant to the neurobiology of alcohol abuse and alcoholism.
Hnrnph1 是一种经过验证的、可量化的安非他命行为敏感性的数量性状基因,编码异质性核核糖核蛋白 H1(hnRNP H1)。这种 RNA 结合蛋白参与 RNA 代谢的所有阶段,影响中皮层边缘多巴胺神经传递,从而影响与成瘾相关的行为。
我们对 Hnrnph1 第一个编码外显子缺失的杂合子(Hnrnph1+/-)小鼠的酒精行为表型进行了特征描述。我们在连续和有限接触程序下检查了酒精摄入量,以及酒精诱导的位置条件反射。后续研究检查了基因型差异对急性和重复酒精的精神运动激活和镇静催眠作用,以及行为测试组合用于确定 Hnrnph1 缺失对酒精戒断期间负面情绪表现的影响。
与野生型(WT)对照组相比,Hnrnph1+/- 雄性在两种饮酒程序下对高酒精浓度的摄入量都较低。Hnrnph1 缺失不影响低剂量酒精的条件性奖赏作用,但逆转了较高酒精剂量(2 和 4 g/kg)引起的条件性厌恶,在雄性小鼠中比雌性小鼠更明显。基因型差异对酒精引起的运动活动没有影响。Hnrnph1+/- 小鼠对酒精的镇静催眠作用敏感性略有增加,但在酒精镇静催眠作用的耐受性或酒精代谢方面与 WT 小鼠无差异。在戒断引起的负面情绪模型中观察到 Hnrnph1 缺失的不一致影响。
这些数据表明 Hnrnph1 是一种新的、雄性选择性的酒精消费和高剂量酒精厌恶的驱动因素,可能与酒精滥用和酗酒的神经生物学有关。